{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:35:52Z","timestamp":1775032552811,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterized by autoantibody production and immune complex-mediated organ damage, frequently involving the kidneys as lupus nephritis (LN). However, reliable blood-based biomarkers for disease activity and renal involvement remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed serum proteomic profiling in newly diagnosed SLE patients and integrated these data with renal transcriptomic datasets from SLE mouse models to identify candidate biomarkers. Associations between serum RNASE1 levels and clinical parameters were evaluated, and a composite RNASE1-albumin-calcium (RAC) score was developed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>RNASE1 was consistently upregulated in both serum and renal tissues of SLE patients. Serum RNASE1 levels were significantly elevated compared with healthy controls and showed positive correlations with proteinuria and SLE Disease Activity Index (SLEDAI) scores, and a negative correlation with complement C3. The RAC score demonstrated stronger correlations with disease activity and renal function than RNASE1 alone. Receiver operating characteristic (ROC) analysis showed that the RAC score discriminated SLE disease activity with area under the curve (AUC) values of 0.7654, 0.7737, and 0.8072 for \u2265mild, \u2265moderate, and \u2265severe activity, respectively. In addition, renal RNASE1 expression increased with LN severity and was significantly higher in class IV \u00b1 V LN than in class III \u00b1 V or class V LN, correlating with the pathological activity index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>RNASE1 is a promising biomarker reflecting both systemic disease activity and renal involvement in SLE. The RNASE1-based RAC score provides a noninvasive tool for improved disease assessment and may facilitate clinical monitoring and management of SLE patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1790455","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:42:36Z","timestamp":1775022156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum RNASE1 as a biomarker for disease activity and lupus nephritis in systemic lupus erythematosus"],"prefix":"10.3389","volume":"17","author":[{"given":"Jianping","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuquan","family":"Jin","sequence":"additional","affiliation":[{"name":"Key Laboratory of Multi-Cell Systems, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences","place":["Shanghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deguang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University","place":["Hefei, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073980","article-title":"Advances in the management of systemic lupus erythematosus","volume":"383","author":"Morand","year":"2023","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-7-201310010-01004","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41584-024-01158-w","article-title":"Lupus nephritis-related chronic kidney disease","volume":"20","author":"Lichtnekert","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"11","author":"Parodis","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1681\/asn.v102413","article-title":"Lupus nephritis","volume":"10","author":"Cameron","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.kint.2024.10.018","article-title":"Lupus nephritis: redefining the treatment goals","volume":"107","author":"De Vriese","year":"2025","journal-title":"Kidney Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2023.100772","article-title":"Kidney biopsy in management of lupus nephritis: a case-based narrative review","volume":"6","author":"Rodriguez-Ramirez","year":"2024","journal-title":"Kidney Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020805","article-title":"Lupus nephritis biomarkers: a critical review","volume":"25","author":"Alduraibi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.576491","article-title":"Endothelial ribonuclease 1 in cardiovascular and systemic inflammation","volume":"8","author":"Bedenbender","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.619221","article-title":"Extracellular RNA as a versatile DAMP and alarm signal that influences leukocyte recruitment in inflammation and infection","volume":"8","author":"Preissner","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131571","article-title":"Ribonuclease 1 attenuates septic cardiomyopathy and cardiac apoptosis in a murine model of polymicrobial sepsis","volume":"5","author":"Zechendorf","year":"2020","journal-title":"JCI Insight"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.84592","article-title":"Ribonuclease 1 enhances antitumor immunity against breast cancer by boosting T cell activation","volume":"19","author":"Wang","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404961","article-title":"Ribonuclease 1 induces T-cell dysfunction and impairs CD8(+) T-cell cytotoxicity to benefit tumor growth through hijacking STAT1","volume":"12","author":"Yang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-025-02206-x","article-title":"RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer","volume":"10","author":"Zha","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41467-024-45215-0","article-title":"Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000507213","article-title":"A validation of the 2018 revision of International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: a cohort study from China","volume":"51","author":"Tao","year":"2020","journal-title":"Am J Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2019.03.003","article-title":"Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology","volume":"70","author":"Lee","year":"2019","journal-title":"Mol Aspects Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17081278","article-title":"The ribonuclease A superfamily in humans: canonical RNases as the buttress of innate immunity","volume":"17","author":"Koczera","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107944","article-title":"Extracellular RNA drives TNF-alpha\/TNF-receptor-1 mediated cardiac ischemia\/reperfusion injury: mechanistic insights and therapeutic potential of RNase1","volume":"221","author":"Cabrera-Fuentes","year":"2025","journal-title":"Pharmacol Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105284","article-title":"The role of human ribonuclease A family in health and diseases: a systematic review","volume":"25","author":"Sun","year":"2022","journal-title":"iScience"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201900451r","article-title":"Inflammation-mediated deacetylation of the ribonuclease 1 promoter via histone deacetylase 2 in endothelial cells","volume":"33","author":"Bedenbender","year":"2019","journal-title":"FASEB J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106430","article-title":"Ribonuclease attenuates acute intestinal injury induced by intestinal ischemia reperfusion in mice","volume":"83","author":"Zhang","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2025.100874","article-title":"Ribonuclease activity undermines immune sensing of naked extracellular RNA","volume":"5","author":"Castellano","year":"2025","journal-title":"Cell Genom"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000036243","article-title":"Screening of potential biomarkers of system lupus erythematosus based on WGCNA and machine learning algorithms","volume":"102","author":"Li","year":"2023","journal-title":"Med (Baltimore)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9588","DOI":"10.1038\/s41598-025-93771-2","article-title":"High disease activity correlate with decreased serum calcium in systemic lupus erythematosus","volume":"15","author":"Du","year":"2025","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091028","article-title":"Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus","volume":"37","author":"Yip","year":"2010","journal-title":"J Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2018-000271","article-title":"Serum albumin at 1 year predicts long-term renal outcome in lupus nephritis","volume":"5","author":"Domingues","year":"2018","journal-title":"Lupus Sci Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1580146","article-title":"Clinical characteristics, prognosis, and predictive modeling in class IV +\/- V lupus nephritis","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-jbn-2024-0118en","article-title":"Renal outcomes in the long-term follow-up of lupus nephritis","volume":"47","author":"Polycarpo","year":"2025","journal-title":"J Bras Nefrol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1790455\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:42:37Z","timestamp":1775022157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1790455\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2026.1790455"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1790455","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1790455"}}